Wall Street used to be about the Magnificent Seven. Now it's just about the three giants: Apple, Nvidia and Microsoft, all worth more than $US3 trillion each. So how should investors think about these behemoths?William Liu, Senior Investment Analyst at WAM Global, talks to Sean Aylmer about the outlook for the big three.This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Sean Aylmer, Michael Thompson and Adam Lang each nominate their top local corporate story from the year - and choose a winner.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Music is big business - even more so in recent years, with artists like Justin Bieber, Bob Dylan and Bruce Springsteen selling their catalogues for hundreds of millions of dollars.But as Stefan von Imhof from alternative investing community alts.co explains - investing in music isn’t beyond the reach of ordinary investors. This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Sean Aylmer, Michael Thompson and Adam Lang each nominate their favourite story from the year, the gift that keeps on giving - and choose a winner.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

2024 has been quite the year - local and international markets set records, as did gold, and Bitcoin, and more.Grady Wulff, Market Analyst at Bell Direct, gives her take on the outlook for 2025 and what it means for investors.This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Sean Aylmer, Michael Thompson and Adam Lang each nominate their top international story from the year - and choose a winner.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Logistics company Brambles, glass bottle manufacturer Orora and waste business Cleanaway - three very different companies, but three fascinating stories. Jakob Cakarnis, Director of Equity Research at Jarden Australia, tells Sean Aylmer what he likes and dislikes about them.This is Fear & Greed's summer investing series. All information is general in nature - you should seek independent professional advice before making investment decisions.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Sean Aylmer, Michael Thompson and Adam Lang each nominate their top markets story from the year - and choose a winner.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Guest: Mesoblast founder Silviu Itescu Original air date: March 9, 2022 ASX-listed biotech Mesoblast is spoken about a lot on Fear and Greed due to its extremely volatile share price. This is largely tied to some big medical breakthroughs they've been working on for a long time.   Founder Silviu Itescu discusses the exhaustive and expensive process behind getting critical new drugs developed, tested and approved and the possible announcements that are coming. Update: Mesoblast's share price increased by 50% in just one day this week after the US FDA gave the green light to another one of its treatments. Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.

Sean Aylmer and Michael Thompson go head to head on the top business stories of the week, with Fear & Greed colleague Adam Lang adjudicating.Find out more: https://fearandgreed.com.auSee omnystudio.com/listener for privacy information.